EGFR and cancer: It is worth pointing out that since proteins within Gene EGFR and Gene HRAS affect multiple cancers as compared to proteins within Gene MAPK3 which are unique to each type of cancer, the cost benefit payoff ratio would be higher for Gene EGFR and Gene HRAS than for Gene MAPK3.